Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shaker A Mousa

Showing results (71-80 of 435) with videos related to

Pageof 44
Sort By:
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 24, 2017
Recent advances in management of autosomal-dominant polycystic kidney diseaseJacob W Potts, Shaker A Mousa
Journal of Cellular Biochemistry|March 14, 2007
Neutrophil-activating protein-2- and interleukin-8-mediated angiogenesisJohn A Powell, Shaker A Mousa
Thrombosis and Haemostasis|August 5, 2009
Anti-cancer properties of low-molecular-weight heparin: preclinical evidenceShaker A Mousa, Lars J Petersen
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|June 21, 2014
Mayer-Rokitansky-Kuster-Hauser syndrome: complications, diagnosis and possible treatment options: a reviewDavid S Bombard, Shaker A Mousa
Journal of Alternative and Complementary Medicine (New York, N.Y.)|February 21, 2012
The shortcomings of clinical trials assessing the efficacy of probiotics in irritable bowel syndromeNathan J Rogers, Shaker A Mousa
Methods in Molecular Biology (Clifton, N.J.)|June 7, 2013
Relevance of nanotechnology in modulating oxidative stress: an overviewDhruba J Bharali, Shaker A Mousa
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 3, 2020
Cancer-Associated Thrombosis: Risk Factors, Molecular Mechanisms, Future ManagementMarwa S Hamza, Shaker A Mousa
Cancers|November 12, 2013
Nanotechnology-based detection and targeted therapy in cancer: nano-bio paradigms and applicationsShaker A Mousa, Dhruba J Bharali
Nanomedicine (London, England)|February 4, 2022
Clinical application of nano-targeting for enhancing chemotherapeutic efficacy and safety in cancer managementMatthew C Phillips, Shaker A Mousa
Methods in Molecular Biology (Clifton, N.J.)|July 10, 2010
Diagnosis and management of sickle cell disordersShaker A Mousa, Mohamad H Qari
Pageof 44

Showing results (71-80 of 435) with videos related to

Sort By:
Pageof 44
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|November 24, 2017
Recent advances in management of autosomal-dominant polycystic kidney diseaseJacob W Potts, Shaker A Mousa
Journal of Cellular Biochemistry|March 14, 2007
Neutrophil-activating protein-2- and interleukin-8-mediated angiogenesisJohn A Powell, Shaker A Mousa
Thrombosis and Haemostasis|August 5, 2009
Anti-cancer properties of low-molecular-weight heparin: preclinical evidenceShaker A Mousa, Lars J Petersen
Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology|June 21, 2014
Mayer-Rokitansky-Kuster-Hauser syndrome: complications, diagnosis and possible treatment options: a reviewDavid S Bombard, Shaker A Mousa
Journal of Alternative and Complementary Medicine (New York, N.Y.)|February 21, 2012
The shortcomings of clinical trials assessing the efficacy of probiotics in irritable bowel syndromeNathan J Rogers, Shaker A Mousa
Methods in Molecular Biology (Clifton, N.J.)|June 7, 2013
Relevance of nanotechnology in modulating oxidative stress: an overviewDhruba J Bharali, Shaker A Mousa
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|September 3, 2020
Cancer-Associated Thrombosis: Risk Factors, Molecular Mechanisms, Future ManagementMarwa S Hamza, Shaker A Mousa
Cancers|November 12, 2013
Nanotechnology-based detection and targeted therapy in cancer: nano-bio paradigms and applicationsShaker A Mousa, Dhruba J Bharali
Nanomedicine (London, England)|February 4, 2022
Clinical application of nano-targeting for enhancing chemotherapeutic efficacy and safety in cancer managementMatthew C Phillips, Shaker A Mousa
Methods in Molecular Biology (Clifton, N.J.)|July 10, 2010
Diagnosis and management of sickle cell disordersShaker A Mousa, Mohamad H Qari
Pageof 44